ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Ulcer
Kidney Diseases

Diabetes trials near Indianapolis, IN, USA:

Incorporating Mind-body Skills With Diabetes Education in Adolescents With Type 1 Diabetes

Adolescence presents a challenging time for type 1 diabetes management, and despite a multitude of studies aimed at increasing disease compl...

Active, not recruiting
Type 1 Diabetes
Adolescent Behavior
Behavioral: Diabetes education
Behavioral: Mind-body skills
Indiana University
Indiana University

Indianapolis, Indiana, United States and 1 other location

Evaluating the adverse events and tolerance of R-5280 in Mitigating Type 1 Diabetes in Newly Diagnosed Patients...

Enrolling
Diabetes Mellitus, Type 1
Type 1 Diabetes
Other: Placebo
Drug: R-5280

Phase 1

Rise Therapeutics

Indianapolis, Indiana, United States and 1 other location

The purpose of this study is to assess the safety and pharmacokinetics (PK) of teplizumab in participants with Stage 2 type 1 diabetes who a...

Enrolling
Diabetes Mellitus, Type 1
Biological: teplizumab

Phase 4

Provention Bio, a Sanofi Company

Indianapolis, Indiana, United States and 9 other locations

The goal of this clinical trial is to test a drug known as DFMO in people with Type 1 Diabetes (T1D). The main question\[s\] it aims to answ...

Enrolling
Type 1 Diabetes
Drug: DFMO
Drug: Placebo

Phase 2

Emily K. Sims

Indianapolis, Indiana, United States and 5 other locations

Hepatic and Cardiovascular endpoints for patients with Type 2 Diabetes who are inadequately controlled with insulin therapy. The purpose of ...

Enrolling
Type 2 Diabetes
Device: Duodenal Mucosal Resurfacing (Sham)
Device: Duodenal Mucosal Resurfacing (DMR)
Fractyl Health

Indianapolis, Indiana, United States and 64 other locations

preserving beta-cell function and delaying the progression of type 1 diabetes (T1D) in adolescent and adult patients. The safety of ladarixi...

Active, not recruiting
New-onset type1 Diabetes
Drug: Placebo
Drug: Ladarixin

Phase 3

Dompé
Dompé

Indianapolis, Indiana, United States and 56 other locations

Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with typ...

Enrolling
Type 1 Diabetes
Device: Subject's Current Diabetes Therapy
Device: 670G and 770G Insulin Pump
Medtronic
Medtronic

Indianapolis, Indiana, United States and 37 other locations

control clinical trial testing two different JAK Inhibitors abrocitnib, ritlecitinib, and placebo in subjects with recent onset Stage 3 Type 1 Diabetes...

Enrolling
Diabetes Mellitus, Type 1
Drug: Abrocitinib 200 MG Oral Tablet
Drug: Placebo

Phase 2

National Institutes of Health (NIH)
National Institutes of Health (NIH)

Indianapolis, Indiana, United States and 15 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Avon, Indiana, United States and 174 other locations

This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested t...

Enrolling
Diabetes Mellitus, Type 2
Drug: Oral semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Indianapolis, Indiana, United States and 87 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems